2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
57
Carcinoma, Hepatocellular
45
Carcinoma, Non-Small-Cell Lung
23
Small Cell Lung Carcinoma
19
Ovarian Neoplasms
18
Colorectal Neoplasms
18
Breast Neoplasms
17
Sarcoma
14
Neoplasms
14
Triple Negative Breast Neoplasms
13
Nasopharyngeal Carcinoma
11
Lung Neoplasms
10
Esophageal Squamous Cell Carcinoma
10
Cholangiocarcinoma
10
Osteosarcoma
9
Esophageal Neoplasms
9
Advanced Gastric Cancer
9
Neoplasm Metastasis
8
Biliary Tract Neoplasms
8
Uterine Cervical Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Recurrence
6
Pancreatic Neoplasms
6
Head and Neck Neoplasms
6
Liver Neoplasms
5
Glioma
5
Thyroid Neoplasms
4
Solid Tumor
4
Melanoma
4
Drug-Related Side Effects and Adverse Reactions
4
Interventions
Gemcitabine
9
130-nm albumin-bound paclitaxel
6
S 1 (combination)
4
Albumin-Bound Paclitaxel
4
toripalimab
3
Taxes
3
Nivolumab
2
Injections
2
Drug Therapy
2
surufatinib
1
penpulimab
1
pegylated granulocyte colony-stimulating factor
1
paricalcitol
1
nimotuzumab
1
irinotecan sucrosofate
1
gimeracil
1
fluzoparib
1
envafolimab
1
endostar protein
1
conteltinib
1
camrelizumab
1
cabiralizumab
1
apatinib
1
Tegafur
1
Simvastatin
1
Radiosurgery
1
Paclitaxel
1
Oxaliplatin
1
Metformin
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Pancreatic Cancer
×
apatinib
×
Clear all
NCT03662035
2018-09-19
ASPC
Changzhou No.2 People's Hospital
Phase 2
Unknown
30 enrolled